Additional file 1 of GenoMycAnalyzer: a web-based tool for species and drug resistance prediction for Mycobacterium genomes

Additional file 1: Table S1. Major functions of GenoMycAnalyzer compared to other whole genome sequencing analysis tools. Table S2. NTM genomes newly added to custom-built database. Table S3. Drugs and resistance-associated genes investigated in this study. Table S5. Significance of difference in AUC between two datasets. Table S8. Comparison of large deletion and pDST results. Table S9. GenoMycAnalyzer species predictions compared to those of the NCBI report. Table S10. GenoMycAnalyzer sub-species predictions compared to those of the NCBI report. Table S12. Comparison of GenoMycAnalyzer spoligotype predictions with reported spoligotype for 54 MTBC isolates

S1 File -

(PDF)</p

Relationship between the fluconazole usage and the percentage of isolates with non-susceptible to fluconazole, or isolates with decreased susceptibility to fluconazole (MIC ≥4 μg/ml) at nine university hospitals in Korea.

<p>The usage of fluconazole, defined as the daily dose/1,000 patient days (DDD/1,000 PD) at the individual hospital was represented by the grey columns. The percentage of isolates with non-susceptible to fluconazole (closed circle with solid line) and the percentage of isolates with decreased susceptibility to fluconazole (MIC ≥4 μg/ml) (open rectangle with dotted line) showed positive correlations with the usage of fluconazole at the individual hospitals.</p